Drawing for CANCER HOPE INSTITUTE

USPTO serial 78609967

CANCER HOPE INSTITUTE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
KEAM, ALEX S
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANCER HOPE INSTITUTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronni S. Jillions

RONNI S JILLIONS BROWDY & NEIMARK624 9TH ST NW STE 300WASHINGTON, DC 20001-5304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035PROMOTING MEDICAL AND SCIENTIFIC RESEARCH BY ENTITIES, NAMELY, UNIVERSITIES, RESEARCH INSTITUTES, HOSPITALS, AND FOUNDATIONS, IN THE FIELD OF CANCER, ITS CAUSES, PREVENTION, TREATMENT AND DIAGNOSIS, AND BIOMEDICAL SCIENCESABANDONED—
036PROMOTING AND SUPPORTING ENTITIES, NAMELY, UNIVERSITIES, RESEARCH INSTITUTES, HOSPITALS, AND ORGANIZATIONS INVOLVED IN OR DEDICATED TO CANCER CURE RESEARCH, NAMELY, BY PROVIDING FINANCIAL SUPPORT AND CHARITABLE FUNDRAISING; PROVIDING RESEARCH GRANTS TO VARIOUS ORGANIZATIONS, NAMELY UNIVERSITIES, RESEARCH INSTITUTES, FOUNDATIONS AND HOSPITALS AIMED AT REDUCING THE INCIDENCE AND IMPACT OF CANCER IN THE COMMUNITY; FINANCIAL SPONSORSHIP OF SEMINARS, CONFERENCES AND SESSIONS FOR ENTITIES, NAMELY, UNIVERSITIES, RESEARCH INSTITUTES, HOSPITALS, AND FOUNDATIONS, DEDICATED TO MATTERS RELATED TO CANCER CURE AND CANCER PREVENTIONABANDONED—
041EDUCATIONAL SERVICES, NAMELY, CONDUCTING WORKSHOPS AND SEMINARS FOR ENTITIES, NAMELY, UNIVERSITIES, RESEARCH INSTITUTES, HOSPITALS, AND FOUNDATIONS, IN THE FIELD OF CANCER AND HEALTH AWARENESS AIMED AT REDUCING THE INCIDENCE AND IMPACT OF CANCER IN THE COMMUNITYABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2007EXPTEXPARTE APPEAL TERMINATED—
Oct 19, 2007MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Oct 19, 2007ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 10, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
May 10, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 17, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2007NPUBNOTICE OF PUBLICATION—
Feb 27, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 27, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2007ALIEASSIGNED TO LIE—
Feb 13, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 13, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2007EXPIEX PARTE APPEAL-INSTITUTED—
Feb 13, 2007JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Feb 13, 2007EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Aug 16, 2006CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 16, 2006CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 11, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 25, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 25, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2006CNSLLETTER OF SUSPENSION MAILED—
May 30, 2006CNSLSUSPENSION LETTER WRITTEN—
May 25, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 10, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 10, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 17, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2005DOCKASSIGNED TO EXAMINER—
May 12, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 9, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 9, 2005PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 22, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance